Microba Life Sciences Limited (ASX:MAP)

Microba Life Sciences Income Statement

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Revenue	14.9	15.67	12.09	5.42	4.69	3.73
Revenue Growth (YoY)	-11.81%	29.60%	123.06%	15.60%	25.62%	28.31%
Cost of Revenue	7.93	8.23	6.18	2.74	2.32	1.69
Gross Profit	6.97	7.44	5.91	2.68	2.37	2.04
Selling, General & Admin	22.18	22.52	16.01	10.18	10.27	7.31
Research & Development	1.54	2.01	10.84	9.34	5.38	2.1
Other Operating Expenses	3.3	3.09	2.03	1.75	1.44	0.93
Operating Expenses	31.48	32.05	31.74	22.91	18.64	11.56
Operating Income	-24.51	-24.61	-25.84	-20.23	-16.27	-9.52
Interest Expense	-0.18	-0.18	-0.07	-0.06	-0.06	-0.02
Interest & Investment Income	0.43	0.58	1	0.88	0.05	0.1
Currency Exchange Gain (Loss)	0.08	1.76	0.1	0.37	0.49	-0.05
Other Non Operating Income (Expenses)	2.93	2.93	5.82	6.37	4.32	1.97
EBT Excluding Unusual Items	-21.25	-19.52	-18.98	-12.67	-11.46	-7.52
Merger & Restructuring Charges	-	-	-1.01	-	-	-
Gain (Loss) on Sale of Assets	-0.02	-	-	-	-	-
Other Unusual Items	2.05	4.47	-	-	-	-
Pretax Income	-19.97	-15.05	-19.99	-12.67	-11.46	-7.52
Income Tax Expense	-0.22	-0.11	-0.05	0.01	0.01	-
Net Income	-19.75	-14.94	-19.94	-12.68	-11.47	-7.52
Net Income to Common	-19.75	-14.94	-19.94	-12.68	-11.47	-7.52
Shares Outstanding (Basic)	518	448	410	314	223	183
Shares Outstanding (Diluted)	518	448	410	314	223	183
Shares Change (YoY)	15.66%	9.40%	30.42%	40.87%	21.61%	17.01%
EPS (Basic)	-0.04	-0.03	-0.05	-0.04	-0.05	-0.04
EPS (Diluted)	-0.04	-0.03	-0.05	-0.04	-0.05	-0.04
Free Cash Flow	-15.38	-12.34	-17.05	-12.94	-12.08	-7.43
Free Cash Flow Per Share	-0.03	-0.03	-0.04	-0.04	-0.05	-0.04
Gross Margin	46.77%	47.49%	48.84%	49.41%	50.46%	54.61%
Operating Margin	-164.43%	-157.05%	-213.71%	-373.24%	-347.05%	-255.09%
Profit Margin	-132.53%	-95.34%	-164.92%	-233.95%	-244.64%	-201.58%
Free Cash Flow Margin	-103.22%	-78.75%	-141.06%	-238.82%	-257.75%	-199.04%
EBITDA	-23.06	-22.47	-23.67	-19.09	-15.56	-8.95
EBITDA Margin	-154.71%	-143.43%	-195.80%	-	-	-239.87%
D&A For EBITDA	1.45	2.13	2.16	1.14	0.72	0.57
EBIT	-24.51	-24.61	-25.84	-20.23	-16.27	-9.52
EBIT Margin	-164.43%	-157.05%	-213.71%	-	-	-255.09%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.